A Prescription Agent
Omeclamox®-Pak is an ethical pharmaceutical that has been approved and is regulated by the US Food and Drug Administration (FDA). Omeclamox-Pak can be obtained only by prescription from a licensed healthcare provider after diligent disclosure by the healthcare provider.
The information provided by this Web site, directory, accompanying articles, and links to other related Web sites is provided as a courtesy to site visitors, and all material is intended for information, communication, and education purposes only, and is in no manner an endorsement, recommendation, or approval by anyone of any product or of any treatment. The information presented is not to be considered complete, nor does it contain all medical information that may be relevant, and therefore it is not intended as a substitute for seeking medical treatment and/or appropriate care, nor is the information intended to replace medical advice offered by physicians. It should not be construed as rendering medical advice.
For information on use of the individual components when dispensed as individual medications outside this combined use for treating Helicobacter pylori, please see the package inserts for each individual product.
Omeclamox®-Pak (omeprazole, clarithromycin, amoxicillin) is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one-year history of duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
IMPORTANT SAFETY INFORMATION
1. Omeclamox®-Pak complete prescribing information. 02/2016
* Three U.S., randomized, double-blind clinical studies in patients with H. pylori infection and duodenal ulcer disease (n = 558) compared omeprazole plus clarithromycin plus amoxicillin with clarithromycin plus amoxicillin. Two studies (1 and 2) were conducted in patients with an active duodenal ulcer, and the other study (3) was conducted in patients with a history of a duodenal ulcer in the past 5 years but without an ulcer present at the time of enrollment. The combination of omeprazole plus clarithromycin plus amoxicillin was effective in eradicating H. pylori.